AP NEWS
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Business Wire
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.

Telfast - Drug Insight, 2019 - ResearchAndMarkets.com

March 13, 2019

DUBLIN--(BUSINESS WIRE)--Mar 13, 2019--The “Telfast - Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering.

Telfast Drug Insight, 2019 highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location.

The report covers the Global Market Assessment of the Telfast covering the historical global sales and also provides the Telfast sales estimation during the forecasted period (2019-2021).

The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country. In addition to this, the report also provides the SWOT analysis for Telfast and emerging therapies in this space.

Topics Covered

1. Report Introduction

2. Telfast - Overview

  • Product Description
  • Route of Synthesis
  • Mechanism of Action
  • Pharmacology
  • Pharmacodynamics
  • Pharmacokinetics
  • Adverse Reactions
  • Regulatory Milestones by Region
  • Deals and Partnerships

3. Product Details

4. Telfast Sales Assessment

  • Historical Sales
  • Forecasted Sales

5. Patent Details

6. Global API Manufacturers Assessment

  • Active Pharmaceutical Ingredient (API) Manufacturers by Country
  • Active Pharmaceutical Ingredient (API) Manufacturers by Region

7. Market Competition

8. Emerging Therapies

8.1 Drug 1: Company 1

  • Product Description
  • Research and Development
  • Product Development Activities

9. SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/research/ct7t4k/telfast_drug?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190313005353/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Immune Disorders Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 03/13/2019 06:54 AM/DISC: 03/13/2019 06:54 AM

http://www.businesswire.com/news/home/20190313005353/en